Incremental test to exhaustion during cycling exercise from 65-85% of maximum exertion in 4 subjects ingesting placebo and MELT3TM tocotrienols (40mg/d) for 3 weeks, with a washout-period of 4 days between treatments. Exercise tests were conducted at the end of each 3 week period of supplementation.
Delayed onset muscle soreness (DOMS) on visual analogue scale 1 and 2 days after eccentric forearm contraction.
* Results based on previous formulation indicative of melt
Two soccer players were assessed by the team occupational therapist to have muscle soreness in their thighs and legs from over-exercise and were ordered to rest prior to reassessment.
The two people were administered a single 40mg of NE1-Elite® dose daily for a week.
The soreness, in their words, “disappeared” and they were reassessed by the occupational therapists and deemed to be fit for training.
They also observed that they had no DOMS after training whereas previously they observed significant DOMS regularly.
Two serious recreational bike riders (both cycle at least about 100 kilometres per week) were administered single 40mg daily doses of NE1-Elite® for two weeks prior to a 180 km bike race.
These two riders have competed in this road race for the last ten years. Each time, on completion, their thigh and leg muscles were sore the day after the ride.
After administration of NE1-Elite® the two cyclists reported slight stiffness in their leg muscles 24 hours after the race and no detectable soreness or stiffness 48 hours after the race. In fact, one of the cyclists trained in the gym the day after.
Two competitive netball players were administered single 40mg daily doses of NE1-Elite® for two weeks.
These two players experienced significant DOMS after weight training in the gym and after a competitive match prior to administration of NE1-Elite®.
Both players reported feeling no DOMS after training in the gym or a competition game.
Watch NE1-Elite® Ambassador Ryan McBean introduce the product.
Less pronounced hanging arm angle in NE1-Elite® group than in Control. Indicates:
Muscle soreness increased in Control group and decreased with NE1-Elite™
(24-hours post exercise P=0.05)
Greater peak power (cycle sprint) in NE1-Elite® group than in Control.
Indicates improved muscle power maintenance.
Helps endurance by staying stronger for longer.
24-hours post exercise (P=0.056)
* Top-line results from US Human Research (Clinical) study for NE1-Elite at University of Mount Union, Ohio, April 2016.